US-based company that deals with diagnostic information services Quest Diagnostics (NYSE: DGX) announced its quarterly cash dividend on Wednesday 14 August.
The company has declared quarterly cash dividend of USD0.75 per share. The dividend will be paid to shareholders of record at 4 October 2024 on 21 October 2024.
Quest provides diagnostic insights from the results of its laboratory testing to empower people, physicians and organisations to take action to improve health outcomes.
Labcorp announces cash dividend
Gilead expands global access to lenacapavir for HIV prevention
Bruker acquires Dynamic Biosensors